BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 9504692)

  • 41. Epstein-Barr virus-related atypical lymphoproliferative disorders in Waldeyer's ring: a clinicopathological study of 9 cases.
    Kojima M; Nakamura N; Itoh H; Shimizu K; Shimizu K; Matsuda H; Tamaki Y; Masawa N; Nakamura S
    Pathobiology; 2010; 77(4):218-24. PubMed ID: 20616617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
    Higgins JP; van de Rijn M; Jones CD; Zehnder JL; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):236-47. PubMed ID: 10941339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation.
    Lau SK; Chen YY; Berry GJ; Yousem SA; Weiss LM
    Mod Pathol; 2003 Dec; 16(12):1242-7. PubMed ID: 14681325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population.
    Itakura O; Yamada S; Narita M; Kikuta H
    Oncogene; 1996 Oct; 13(7):1549-53. PubMed ID: 8875994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients.
    Camilleri-Broët S; Camparo P; Mokhtari K; Hoang-Xuan KH; Martin A; Arborio M; Hauw JJ; Raphaël M
    Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EBV-NK cells interactions and lymphoproliferative disorders.
    Kanegane H; Yachie A; Miyawaki T; Tosato G
    Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus.
    Chang KL; Flaris N; Hickey WF; Johnson RM; Meyer JS; Weiss LM
    Mod Pathol; 1993 Jul; 6(4):427-32. PubMed ID: 8415586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
    Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
    J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological, immunological and genetic studies of CD30+ anaplastic large cell lymphoma of B-cell type; association with Epstein-Barr virus in a Japanese population.
    Kuze T; Nakamura N; Hashimoto Y; Abe M; Wakasa H
    J Pathol; 1996 Nov; 180(3):236-42. PubMed ID: 8958798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
    Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
    Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients.
    Karim N; Pallesen G
    Malays J Pathol; 2003 Jun; 25(1):45-7. PubMed ID: 16196377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No significant role of Epstein-Barr virus in the tumorigenesis of Warthin tumor.
    Ogata T; Hongfang Y; Kayano T; Hirai K
    J Med Dent Sci; 1997 Jun; 44(2):45-52. PubMed ID: 9608281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma.
    Ilyas M; Niedobitek G; Agathanggelou A; Barry RE; Read AE; Tierney R; Young LS; Rooney N
    J Pathol; 1995 Oct; 177(2):115-22. PubMed ID: 7490676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
    Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus infection in non-carcinomatous gastric epithelium.
    Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K
    J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas.
    Ho JW; Ho FC; Chan AC; Liang RH; Srivastava G
    J Pathol; 1998 May; 185(1):79-85. PubMed ID: 9713363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.